Introduction: Carmustine PLGA characterization sits at the intersection of polymer science, oncology pharmacology, and regulatory compliance — making it one […]
Introduction: Aripiprazole lauroxil (Aristada®) is a PLGA-based long-acting injectable antipsychotic that differs fundamentally from other LAI microsphere products. As discussed
Introduction: Goserelin PLGA implant characterization is one of the most technically demanding challenges in long-acting parenteral development — and also
Introduction to Interfacial Dynamics of Surfactants and Emulsifiers in PLGA Microsphere Fabrication The primary function of surfactants and emulsifiers in
Role of Surfactants and Emulsifiers in PLGA Microsphere Fabrication by Double Emulsion Read More »
Introduction: Naltrexone PLGA microsphere burst release is one of the most technically demanding problems in long-acting injectable (LAI) formulation science.
Naltrexone PLGA Microsphere Case Study: Controlling Burst Release Through Polymer Design Read More »
Introduction Sustained-release ocular drug delivery continues to represent a major bioengineering challenge because the eye possesses multiple anatomical and physiological
PLGA-Based Ocular Drug Delivery: Implants, Microspheres, and Injectable Systems Read More »
Introduction: Why the Erosion Mechanism Is Everything The most critical factor in PLGA formulation design is not particle size or
Bulk Erosion vs Surface Erosion in PLGA: How Degradation Mechanism Controls Drug Release Read More »
Introduction: For manufacturers pursuing approval of a generic PLGA-based injectable depot product, demonstrating PLGA polymer sameness for an ANDA submission
Introduction: Why Characterization of Long-Acting Biologics in PLGA Demands a Dedicated Framework The characterization of long-acting biologics encapsulated within poly(lactic-co-glycolic
Characterization of Long-Acting Biologics in PLGA Systems Read More »
Introduction The Glass Transition Temperature (Tg) of PLGA is far more than a routine material specification. It functions as the
